Yili L Pritchett

Author PubWeight™ 10.03^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.	Pain Med	2005	1.99
2	The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders.	J Pain	2009	1.63
3	Baseline observation carry forward: reasoning, properties, and practical issues.	J Biopharm Stat	2009	1.13
4	Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?	Int Clin Psychopharmacol	2006	1.08
5	An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.	Pain Med	2007	0.93
6	Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study.	Psychopharmacology (Berl)	2011	0.91
7	Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain.	Diabetes Care	2007	0.90
8	Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine.	Int Clin Psychopharmacol	2008	0.87
9	Adaptive, dose-finding phase 2 trial evaluating the safety and efficacy of ABT-089 in mild to moderate Alzheimer disease.	Alzheimer Dis Assoc Disord	2015	0.78